Seung-Jung Park
83
14
18
42
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 70/100
26.5%
22 terminated/withdrawn out of 83 trials
65.6%
-20.9% vs industry average
37%
31 trials in Phase 3/4
0%
0 of 42 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (83)
Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice
Role: lead
IRIS-Coroflex NEO Cohort
Role: lead
Fractional Flow Reserve Versus Angiography for Treatment-Decision and Evaluation of Significant Left MAIN Coronary Artery Disease
Role: lead
IRIS- DESyne X2 in the IRIS-DES Registry
Role: lead
IRIS-Onyx Cohort in the IRIS-DES Registry
Role: lead
The DECISION-CTO Extended 10 Y Follow-up
Role: lead
PREventive Invasive Strategy for Obstructive Coronary Artery Disease With Vulnerable Plaque Evaluated by CoroNary Computed Tomography Angiography-2
Role: lead
Effect of FFR Guided Percutaneous Coronary Intervention in Coronary Tandem Lesions
Role: lead
Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization
Role: lead
Study of the Natural History of FFR Guided Percutaneous Coronary Intervention
Role: lead
Observational Study for Left Main Disease Treatment
Role: lead
Asan Multivessel Registry
Role: lead
Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical Practice
Role: lead
Evaluation of Effectiveness and Safety of Aortic Valve Replacement in Routine Clinical Practice
Role: lead
Asan Medical Center Myocardial Infarction Registry
Role: lead
Optical Coherence Tomography Versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention
Role: lead
Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice
Role: lead
Prognosis of Coronary Stenosis Based on Intracoronary Imaging; A Multicenter, Prospective Observational Study
Role: lead
Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice
Role: lead
Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry)
Role: lead